Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "CAS"

1719 News Found

Venus Remedies' R3SET forays into wellness
News | December 20, 2023

Venus Remedies' R3SET forays into wellness

The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey


Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Drug Approval | December 18, 2023

Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease

Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation


Ami Organics inks agreement with Fermion for two additional APIs
News | December 18, 2023

Ami Organics inks agreement with Fermion for two additional APIs

The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25


Lupin receives USFDA approval for Allopurinol Tablets
Drug Approval | December 17, 2023

Lupin receives USFDA approval for Allopurinol Tablets

The product will be manufactured at Lupin's Pithampur facility in India


AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China
News | December 08, 2023

AbelZeta Pharma, AstraZeneca to co-develop a novel GPC3 armored CAR-T therapy in China

C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II


Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign
News | December 06, 2023

Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign

The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets


Roche to acquire Carmot Therapeutics for US$ 2.7 billion
News | December 05, 2023

Roche to acquire Carmot Therapeutics for US$ 2.7 billion

Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases


INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application
Sustainability | December 03, 2023

INEOS Styrolution’s NAS Eco cuts CO2 emissions by 93% in healthcare application

The new ECO grade is made using renewable feedstock


AIIA initiates training programme on latent tuberculosis infections
Healthcare | December 02, 2023

AIIA initiates training programme on latent tuberculosis infections

The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana